Zoltán Kaló is a Professor of Health Economics at Eötvös Loránd University (ELTE) in Budapest. He is the co-director of the international Health Policy, Planning and Financing master program. Dr. Kaló is also the founder and leader of Syreon Research Institute, an international research corporation specializing in health policy, health economic modeling and technology assessment. He received a Bachelor of Economics degree from the Budapest University of Economics; Medical Doctor degree from the Semmelweis University; MSc in Health Economics degree from the University of York; PhD in Pharmaceutical Sciences degree from the Semmelweis University; and DrHabil degree in Sociology from the ELTE University. He has 20 years of international experience in academia and industry, specializing in health systems design, HTA implementation, health economics and outcomes research, economic modeling, patient access and pricing policies of healthcare technologies. Dr. Kaló serves as a policy advisor to public decision-makers and global health care corporations. He is a Scientific Committee member of the Innovative Medicines Initiative 2 Joint Undertaking (IMI2 JU). He was a Director of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) between 2012-2014, and the Chair of ISPOR Central and Eastern European Network Executive Committee between 2013-2015.